Novel Concepts in the Genesis of Hypertension: Role of LOX-1

被引:0
|
作者
Ping Luo
Meiling Yan
Edward D. Frohlich
Jawahar L. Mehta
Changping Hu
机构
[1] Central South University,Department of Pharmacology, School of Pharmaceutical Sciences
[2] Ochsner Clinic Foundation,Division of Cardiovascular Medicine
[3] University of Arkansas for Medical Sciences and the Central Arkansas Veterans Healthcare System,undefined
来源
Cardiovascular Drugs and Therapy | 2011年 / 25卷
关键词
Hypertension; Lectin-like oxidized low-density lipoprotein receptor-1; Oxidative stress; Angiotensin II;
D O I
暂无
中图分类号
学科分类号
摘要
Hypertension is a common disease and a potent risk factor for cardiovascular disease. Tremendous strides have been made in understanding its genesis in the last 2 decades. Hypertension is often clustered with other cardiovascular risk factors, such as dyslipidemia and diabetes. The state of hypertension is often associated with increased vascular oxidative stress. Oxidative stress promotes proliferation and hypertrophy of vascular smooth muscle cell and collagen deposition, leading to thickening of the vascular media and narrowing of the vascular lumen. Oxidative stress also injures endothelium, impairs endothelium-dependent vascular relaxation and increases vascular contractile activity. Further, oxidative stress also oxidizes LDL-cholesterol. It has been shown that oxidized low-density lipoprotein (ox-LDL) activates renin-angiotensin system (RAS) and angiotensin II via its type 1 receptor activates ox-LDL receptor LOX-1. This mutually facilitative cross-talk between ox-LDL and RAS may be an important component in the development of hypertension. Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) is a receptor for ox-LDL. This review summarizes the role of LOX-1 in the pathogenesis of hypertension.
引用
收藏
页码:441 / 449
页数:8
相关论文
共 50 条
  • [1] Novel Concepts in the Genesis of Hypertension: Role of LOX-1
    Luo, Ping
    Yan, Meiling
    Frohlich, Edward D.
    Mehta, Jawahar L.
    Hu, Changping
    CARDIOVASCULAR DRUGS AND THERAPY, 2011, 25 (05) : 441 - 449
  • [2] The new role of LOX-1 in hypertension induced neuronal apoptosis
    Li, Yali
    Duan, Zongming
    Gao, Dengfeng
    Huang, Shengli
    Yuan, Haifeng
    Niu, Xiaolin
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2012, 425 (04) : 735 - 740
  • [4] LOX-1 Transcription
    Hermonat, Paul L.
    Zhu, Hongqing
    Cao, Maohua
    Mehta, Jawahar L.
    CARDIOVASCULAR DRUGS AND THERAPY, 2011, 25 (05) : 393 - 400
  • [5] Oxidized LDL, LOX-1 and Atherosclerosis
    Mitra, Sona
    Goyal, Tanu
    Mehta, Jawahar L.
    CARDIOVASCULAR DRUGS AND THERAPY, 2011, 25 (05) : 419 - 429
  • [6] Role of Ox-LDL and LOX-1 in Atherogenesis
    Kattoor, Ajoe John
    Kanuri, Sri Harsha
    Mehta, Jawahar L.
    CURRENT MEDICINAL CHEMISTRY, 2019, 26 (09) : 1693 - 1700
  • [7] LOX-1: Regulation, Signaling and Its Role in Atherosclerosis
    Kattoor, Ajoe John
    Goel, Akshay
    Mehta, Jawahar L.
    ANTIOXIDANTS, 2019, 8 (07)
  • [8] LOX-1, a possible clue to the missing link between hypertension and atherogenesis
    Kita, T
    CIRCULATION RESEARCH, 1999, 84 (09) : 1113 - 1115
  • [9] LOX-1: A New Target for Therapy for Cardiovascular Diseases
    Mehta, Jawahar L.
    Khaidakov, Magomed
    Hermonat, Paul L.
    Mitra, Sona
    Wang, Xianwei
    Novelli, Guiseppe
    Sawamura, Tatsuya
    CARDIOVASCULAR DRUGS AND THERAPY, 2011, 25 (05) : 495 - 500
  • [10] LOX-1: A New Target for Therapy for Cardiovascular Diseases
    Jawahar L. Mehta
    Magomed Khaidakov
    Paul L. Hermonat
    Sona Mitra
    Xianwei Wang
    Guiseppe Novelli
    Tatsuya Sawamura
    Cardiovascular Drugs and Therapy, 2011, 25 : 495 - 500